Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Empire Metals agrees to sell 75% stake in Eclipse gold assets for A$750,000 to focus on titanium project.

Company Fundamentals
19 May 2026
Proactive Investors
View Source
Bullish
pluang ai news

Empire Metals Ltd has signed a definitive agreement to sell its 75% stake in the Eclipse Mining Lease near Kalgoorlie, Western Australia, for A$750,000. The sale includes a non-refundable deposit of A$50,000 already received, with the remaining A$700,000 payable on completion, which is subject to ministerial approval. This divestment allows Empire Metals to concentrate its resources and management on the Pitfield Titanium Project, one of the world's largest titanium discoveries, with a mineral resource estimate of 2.2 billion tonnes grading 5.1% TiO₂. The company is also reviewing other non-core assets as it accelerates development at Pitfield.

More News

U-BX Technology shares drop 15.6% after announcing a 1-for-25 reverse stock split.

U-BX Technology shares drop 15.6% after announcing a 1-for-25 reverse stock split.

U-BX Technology's stock fell 15.6% in after-hours trading following the announcement of a 1-for-25 reverse stock split effective Friday. The move will reduce the number of outstanding shares significantly to maintain Nasdaq listing compliance. The co...

Company Fundamentals
Bearish
1 hour ago
Dr Martens profits jump 61% as turnaround strategy boosts margins and sales.

Dr Martens profits jump 61% as turnaround strategy boosts margins and sales.

Dr Martens reported a 61% increase in adjusted pre-tax profit to £55 million for the year ending March 29, despite a 2.9% revenue decline to £764.9 million. The company improved gross margins to 66.2% by reducing discounting and focusing on higher-qu...

Company Fundamentals
Bullish
4 hours ago
Coiled Therapeutics starts US OTCQB trading to expand investor access amid promising cancer trial data.

Coiled Therapeutics starts US OTCQB trading to expand investor access amid promising cancer trial data.

Coiled Therapeutics, a clinical-stage oncology company, has begun trading on the US OTCQB Venture Market under the ticker COTXF, allowing US investors to buy shares in dollars during US market hours. This move aims to improve liquidity and broaden it...

Company Fundamentals
Bullish
4 hours ago
IXICO expects 15% revenue growth as AI platform and new partnerships boost clinical trial services

IXICO expects 15% revenue growth as AI platform and new partnerships boost clinical trial services

IXICO PLC, specializing in neuroscience imaging and biomarker analytics for clinical drug trials, forecasts at least 15% revenue growth for the full year. The company raised £10 million in April to accelerate its 'TechBio' strategy, integrating its A...

Company Fundamentals
Bullish
4 hours ago
Currys raises profit forecast after strong UK and Nordic sales growth

Currys raises profit forecast after strong UK and Nordic sales growth

Currys PLC expects its annual adjusted pre-tax profit to reach about £191 million, surpassing previous guidance due to strong sales in the UK and Nordic markets. Group like-for-like sales increased 4% for the full year, with the Nordics showing parti...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App